HOUSE_OVERSIGHT_024101.jpg
1.22 MB
Extraction Summary
0
People
24
Organizations
0
Locations
0
Events
1
Relationships
3
Quotes
Document Information
Type:
Financial investment schedule / appendix
File Size:
1.22 MB
Summary
This document is a confidential financial appendix detailing the investment portfolio of New Leaf Ventures I, L.P. as of March 31, 2014. It lists specific realized and unrealized investments in healthcare and therapeutics companies, providing data on vintage years, costs, values, and gross internal rates of return (IRR). The document is marked with a House Oversight control number, suggesting it is part of a larger investigation, likely involving financial scrutiny.
Organizations (24)
| Name | Type | Context |
|---|---|---|
| New Leaf Ventures I, L.P. | ||
| Aesthetic Sciences Corporation | ||
| Artisan Pharma, Inc. | ||
| Aviir, Inc. | ||
| Barrier Therapeutics, Inc. | ||
| BioRelix, Inc. | ||
| Cerexa, Inc. | ||
| CN Therapeutics, Inc. | ||
| Interlace Medical, Inc. | ||
| Oriel Therapeutics, Inc. | ||
| Pearl Therapeutics, Inc. | ||
| Proteogenix, Inc. | ||
| Stromedix, Inc. | ||
| Transcept Pharmaceuticals, Inc | ||
| Access Closure, Inc. | ||
| Concert Pharmaceuticals, Inc. | ||
| Direct Flow Medical, Inc. | ||
| IlluminOss Medical, Inc. | ||
| Intarcia Therapeutics, Inc. | ||
| Relypsa, Inc. | ||
| ReShape Medical | ||
| Tioga Pharmaceuticals, Inc. | ||
| VaxInnate, Inc. | ||
| House Oversight Committee |
Relationships (1)
Table lists New Leaf Ventures I, L.P. investments in companies such as Intarcia Therapeutics, Pearl Therapeutics, etc.
Full Extracted Text
Complete text extracted from the document (2,416 characters)
New Leaf Ventures I, L.P.
$ amounts in millions, as of March 31, 2014
Please refer to Endnotes I,J,K,L,M and N in this Appendix.
$ amounts in millions, as of March 31, 2014
Please refer to Endnotes I,J,K,L,M and N in this Appendix.
Gross Multiple (Realized Portion) Gross Multiple (Total) Gross IRR
Company Sector Vintage Year Total Cost Realized Value Unrealized Value Total Value
Company Sector Vintage Year Total Cost Realized Value Unrealized Value Total Value
Realized or Partially Realized Investments
Aesthetic Sciences Corporation Healthcare Devices 2006 $ 4.1 $ - $ - $ - - - NM
Artisan Pharma, Inc. Therapeutics 2006 $ 10.8 $ - $ - $ - - - NM
Aviir, Inc. Diagnostics & Infrastructure 2007 $ 16.3 $ 0.9 $ - $ 0.9 0.05 0.05 NM
Barrier Therapeutics, Inc. Therapeutics 2006 $ 8.2 $ 6.4 $ - $ 6.4 0.78 0.78 -11.8%
BioRelix, Inc. Therapeutics 2007 $ 6.3 $ - $ - $ - - - NM
Cerexa, Inc. Therapeutics 2005 $ 8.0 $ 43.4 $ - $ 43.4 5.42 5.42 197.3%
CN Therapeutics, Inc. Therapeutics 2006 $ 0.1 $ - $ - $ - - - NM
Interlace Medical, Inc. Healthcare Devices 2005 $ 7.8 $ 67.3 $ 0.1 $ 67.4 8.62 8.64 84.4%
Oriel Therapeutics, Inc. Therapeutics 2007 $ 11.1 $ 18.8 $ 12.2 $ 31.0 1.70 2.80 49.9%
Pearl Therapeutics, Inc. Therapeutics 2007 $ 28.9 $ 72.3 $ 17.3 $ 89.6 2.50 3.10 33.1%
Proteogenix, Inc. Diagnostics & Infrastructure 2007 $ 9.4 $ 0.8 $ - $ 0.8 0.08 0.08 NM
Stromedix, Inc. Therapeutics 2008 $ 10.7 $ 19.2 $ 22.5 $ 41.7 1.79 3.89 42.0%
Transcept Pharmaceuticals, Inc Therapeutics 2005 $ 15.6 $ 7.1 $ - $ 7.1 0.46 0.46 -11.5%
Aesthetic Sciences Corporation Healthcare Devices 2006 $ 4.1 $ - $ - $ - - - NM
Artisan Pharma, Inc. Therapeutics 2006 $ 10.8 $ - $ - $ - - - NM
Aviir, Inc. Diagnostics & Infrastructure 2007 $ 16.3 $ 0.9 $ - $ 0.9 0.05 0.05 NM
Barrier Therapeutics, Inc. Therapeutics 2006 $ 8.2 $ 6.4 $ - $ 6.4 0.78 0.78 -11.8%
BioRelix, Inc. Therapeutics 2007 $ 6.3 $ - $ - $ - - - NM
Cerexa, Inc. Therapeutics 2005 $ 8.0 $ 43.4 $ - $ 43.4 5.42 5.42 197.3%
CN Therapeutics, Inc. Therapeutics 2006 $ 0.1 $ - $ - $ - - - NM
Interlace Medical, Inc. Healthcare Devices 2005 $ 7.8 $ 67.3 $ 0.1 $ 67.4 8.62 8.64 84.4%
Oriel Therapeutics, Inc. Therapeutics 2007 $ 11.1 $ 18.8 $ 12.2 $ 31.0 1.70 2.80 49.9%
Pearl Therapeutics, Inc. Therapeutics 2007 $ 28.9 $ 72.3 $ 17.3 $ 89.6 2.50 3.10 33.1%
Proteogenix, Inc. Diagnostics & Infrastructure 2007 $ 9.4 $ 0.8 $ - $ 0.8 0.08 0.08 NM
Stromedix, Inc. Therapeutics 2008 $ 10.7 $ 19.2 $ 22.5 $ 41.7 1.79 3.89 42.0%
Transcept Pharmaceuticals, Inc Therapeutics 2005 $ 15.6 $ 7.1 $ - $ 7.1 0.46 0.46 -11.5%
Total Realized or Partially Realized Investments $ 137.3 $ 236.2 $ 52.1 $ 288.3 1.72 2.10 27.5%
Unrealized Investments
Access Closure, Inc. Healthcare Devices 2006 $ 24.7 $ - $ 35.4 $ 35.4 - 1.43 6.1%
Concert Pharmaceuticals, Inc. Therapeutics 2006 $ 6.2 $ - $ 6.8 $ 6.8 - 1.11 1.5%
Direct Flow Medical, Inc. Healthcare Devices 2005 $ 13.0 $ - $ 20.2 $ 20.2 - 1.56 7.1%
IlluminOss Medical, Inc. Healthcare Devices 2008 $ 10.1 $ - $ 9.7 $ 9.7 - 0.97 -0.8%
Intarcia Therapeutics, Inc. Therapeutics 2007 $ 36.9 $ - $ 186.9 $ 186.9 - 5.06 39.9%
Relypsa, Inc. Therapeutics 2007 $ 23.7 $ - $ 61.8 $ 61.8 - 2.60 27.5%
ReShape Medical Healthcare Devices 2006 $ 13.6 $ - $ 13.7 $ 13.7 - 1.01 0.2%
Tioga Pharmaceuticals, Inc. Therapeutics 2005 $ 19.6 $ - $ 7.2 $ 7.2 - 0.37 -14.6%
VaxInnate, Inc. Therapeutics 2006 $ 19.4 $ - $ 19.6 $ 19.6 - 1.01 0.2%
Access Closure, Inc. Healthcare Devices 2006 $ 24.7 $ - $ 35.4 $ 35.4 - 1.43 6.1%
Concert Pharmaceuticals, Inc. Therapeutics 2006 $ 6.2 $ - $ 6.8 $ 6.8 - 1.11 1.5%
Direct Flow Medical, Inc. Healthcare Devices 2005 $ 13.0 $ - $ 20.2 $ 20.2 - 1.56 7.1%
IlluminOss Medical, Inc. Healthcare Devices 2008 $ 10.1 $ - $ 9.7 $ 9.7 - 0.97 -0.8%
Intarcia Therapeutics, Inc. Therapeutics 2007 $ 36.9 $ - $ 186.9 $ 186.9 - 5.06 39.9%
Relypsa, Inc. Therapeutics 2007 $ 23.7 $ - $ 61.8 $ 61.8 - 2.60 27.5%
ReShape Medical Healthcare Devices 2006 $ 13.6 $ - $ 13.7 $ 13.7 - 1.01 0.2%
Tioga Pharmaceuticals, Inc. Therapeutics 2005 $ 19.6 $ - $ 7.2 $ 7.2 - 0.37 -14.6%
VaxInnate, Inc. Therapeutics 2006 $ 19.4 $ - $ 19.6 $ 19.6 - 1.01 0.2%
Total Unrealized Investments $ 167.2 $ - $ 361.4 $ 361.4 - 2.16 15.2%
Total New Leaf Ventures I, L.P. Investments $ 304.5 $ 236.2 $ 413.5 $ 649.7 1.72 2.13 19.1%
90
CONTROL NUMBER 257 - CONFIDENTIAL
HOUSE_OVERSIGHT_024101
CONTROL NUMBER 257 - CONFIDENTIAL
HOUSE_OVERSIGHT_024101
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document